PapersPMID:39683570
Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- adults with type 2 diabetes
What moved
How to read these marks →- Decreases C-reactive protein concentration
moderatereplicated ×5
“The overall effect estimates from the meta-analysis demonstrated a significant reduction in CRP in curcumin compared to placebo, SMD = −0.59, 95%CI (−1.11, −0.07), p = 0.03.”
- Effect
- −0.59 standardised mean difference, 95% CI −1.11 to −0.07
- Decreases fasting blood glucose
moderatereplicated ×6
“The overall evidence showed a statistically significant reduction in FBG in the T2D group from curcumin compared to placebo MD = −11.48 mg/dL, 95%CI (−14.26, −8.70), p < 0.01.”
- Effect
- −11.48 mean difference, 95% CI −14.26 to −8.7
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults with type 2 diabetes, 18 RCTs, 1382 participants (693 curcumin, 689 placebo)
- Participants
- 1,382
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 3
curcumin